T cells, particularly activated CD4(+) cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity

Anti-CD20 monoclonal antibody (mAb) therapy is a mainstay of therapy for B cell malignancies, however many patients fail to respond or eventually develop resistance. The current understanding of mechanisms responsible for this resistance is limited. When peripheral blood mononuclear cells of healthy...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhaoming, Chimenti, Michael S., Strouse, Christopher, Weiner, George J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783893/
https://www.ncbi.nlm.nih.gov/pubmed/34110453
http://dx.doi.org/10.1007/s00262-021-02976-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8783893/
https://www.ncbi.nlm.nih.gov/pubmed/34110453
http://dx.doi.org/10.1007/s00262-021-02976-7

Ejemplares similares